301-310 items (total 704)
Published on May 22, 2023
Elucidation of the Species-Specific Aggregation Mechanism of SOD1 Protein Causing Canine Degenerative Myelopathy
Office of Communications and Public Relations
Published on May 19, 2023
Diversity of Primate "Whole-Brain" Neural Circuits Visualized with Ultra-High Field MRI—A Cross-Disciplinary Primate Brain Specimen Image Repository: An International Research Infrastructure to Accelerate Understanding of the Human Brain and Psychiatric and Neurological Disorders—
Office of Communications and Public Relations
Published on May 18, 2023
Keio University Ranked Third in FY2022 Government Survey on University-Developed Venture Businesses
Office of Communications and Public Relations
Published on May 18, 2023
Development of a Novel Treatment for Cerebral Contusion Combining Genome Editing Technology and iPS Cells
Office of Communications and Public Relations
Published on May 16, 2023
for Startups and Keio UniversityConclude an Agreement to Create New Growth Industries Through the Social Implementation of Research and Educational Achievements, Launching a Collaboration Centered on the "STARTUP DB" Information Platform
Office of Communications and Public Relations
Published on April 28, 2023
How Will Cybernetic Avatars Change the Way We Work? Cybernetic Avatar Experiment at Avatar Robot Cafe DAWN ver.β
Office of Communications and Public Relations
Published on April 28, 2023
Development of a Digital Primate Brain Database Using MRI—Expected to Advance Brain Science as Open Science
Office of Communications and Public Relations
Published on April 27, 2023
Possibility of Reducing Methotrexate, a Key Drug in Rheumatoid Arthritis Treatment, Revealed—A Trial on Methotrexate Dose Reduction When Initiating a Biologic Agent
Office of Communications and Public Relations
Published on April 25, 2023
Elucidating the Role of Innate Immune Cells in Severe COVID-19: An Integrated Analysis of Single-Cell and Genomic Information
Office of Communications and Public Relations
Published on April 25, 2023
Development of a Model to Simulate Antibody Titer Trends after COVID-19 Vaccination
Office of Communications and Public Relations